definiens: OR shall mean, with respect to a Collaboration Product, an interactive face - to - face visit by a Par ty 's sales representative with a physician, designated by the Commercial Lead as a member of the target call audience, at his or her office, at hospitals o r at other locations ( excluding exhibits, displays and other forms of co mmunication not involving face - to - face contact by such sales representative ), during which indicated uses, safety, effectiveness, contraindications, side effe cts, warnings and/or other relevant characteristics of a Collaboration Product as approved by a Regulatory Authority are described in a fair and balanced mann er consistent with the FD&C Act ( or equivalent laws in the Territory ), as appli cable, including, but not limited to, the regulations at 21 CFR Part 202 and using, as necessary or desirable, the Product Labeling ( as defined herein ) or the Promotional Materials ( as defined herein ), in an effort to increase physi cian prescribing preferences of such Collaboration Product for its approved indi cated uses